UTILIZATION OF OPTIMAL MEDICAL PHARMACOTHERAPY IN PATIENTS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: INSIGHTS FROM AN INTEGRATED HEALTHCARE SYSTEM

• Main Authors: Izza Shahid, MBBS (Author), Budhaditya Bose, MS (Author), Eleonora Avenatti, MD (Author), Safi U. Khan, MD MHS (Author), Mohamad B. Taha, MD (Author), Khurram Nasir, MD MPH MSc (Author)
• Format: Book
• Published: Elsevier, 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Therapeutic Area: Pharmacologic Therapy Background: Patients with atherosclerotic cardiovascular disease (ASCVD) and concurrent type 2 diabetes mellitus (T2DM) are at an increased risk for adverse cardiovascular outcomes, and derive significant mortality benefit from secondary prevention therapies....